Shiv K. Gupta

Also affiliated with WinnMed

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma”.

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000845

N/A

0DataRank · unranked

45 citations

Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic +5 more

Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor

Drug Metabolism and Disposition(2021)10.1124/dmd.121.000597

N/A

0DataRank · unranked

12 citations

Shiv K. Gupta, Wenjuan Zhang, Surabhi Talele, Afroz S. Mohammad, Janice K. Laramy +5 more

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac130

N/A

0DataRank · unranked

13 citations

Michael S. Regan, Jessica I. Griffith, Sonia Jain, Sylwia A. Stopka, Danielle M. Burgenske +19 more

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001230

N/A

0DataRank · unranked

11 citations

Wenjuan Zhang, Jiajia Chen, Shiv K. Gupta, Danielle M. Burgenske, Jann N. Sarkaria +2 more

ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma

Nature Communications(2024)10.1038/s41467-024-49316-8

N/A

0DataRank · unranked

33 citations

Shiv K. Gupta, Gary A. Bradshaw, Alexander S. Hunter, Brett L. Carlson, Nery Matias Calmo +5 more

Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0426

N/A

0DataRank · unranked

30 citations

Jessica I. Griffith, Kendra A. Porath, Sneha Rathi, Jiayan Le, Tugce I. Pasa +14 more

DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0003

N/A

0DataRank · unranked

12 citations

Emily J. Smith, Michael S. Regan, Sylwia A. Stopka, Gerard Baquer, Zhiyi Xue +19 more

Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0552

N/A

0DataRank · unranked

12 citations

Sonja Dragojevic, Cameron M. Callaghan, Emily J. Smith, Surabhi Talele, Wenjuan Zhang +15 more

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

Neuro-Oncology(2025)10.1093/neuonc/noaf102

N/A

0DataRank · unranked

7 citations

Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A Odukoya +17 more

PK-PD-efficacy modeling of brigimadlin in MDM2-amplified glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2071

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Danielle M. Burgenske, Katie L. Waller, Paul A. Decker, Matt Kosel +13 more

Pre-clinical modeling of navtemadlin pharmacokinetics (PK), pharmacodynamics (PD), and efficacy in glioblastoma, IDH-wildtype.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2012

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Ann C. Mladek, Tugce I. Pasa, Katie L. Waller, Sylwia A. Stopka +15 more

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0244

N/A

0DataRank · unranked

2 citations

Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer Gantchev +24 more